venBio Partners L.P.

13F Portfolio Filings

Most recent 13F
Q4 2018
Location
San Francisco, CA
CIK
0001737053
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2018 3 38,077 Apellis Pharmaceuticals, Inc, I9SA.HA, VYNE 13F-HR 2/14/2019 000101297519000159
Q3 2018 3 57,170 Apellis Pharmaceuticals, Inc, VYNE, I9SA.HA 13F-HR 11/14/2018 000173705318000003
Q2 2018 4 96,922 Apellis Pharmaceuticals, Inc, I9SA.HA, VYNE, NBRV 13F-HR 8/14/2018 000101297518001014
Q1 2018 4 162,246 Apellis Pharmaceuticals, Inc, VYNE, I9SA.HA, NBRV 13F-HR 4/25/2018 000173705318000002
Q4 2017 3 100,757 Apellis Pharmaceuticals, Inc, NBRV, I9SA.HA 13F-HR 4/25/2018 000173705318000001